Docket Room.
A 11256·NY·house

Requires health plan coverage to include certain generic drugs and biosimilars

In CommitteeFiled May 4, 2026
Sponsor: Josh Jensen
Latest Action

REFERRED TO INSURANCE

May 4, 2026

Email me when A 11256 moves

Committee action, floor votes, amendments and hearings. Free, no card, no password.

Already have an account? Track A 11256. By continuing you agree to the Terms and Privacy Policy.

Legislative status

  1. Introduced
  2. In Committee
  3. Reported by Committee
  4. Floor Vote Scheduled
  5. Passed One Chamber
  6. Passed Both Chambers
  7. Sent to Executive
  8. Signed into Law

Summary

The bill forces New York health insurance policies to add any FDA‑approved generic drug or biosimilar that costs less than its brand counterpart to the plan’s formulary right away. Those drugs must be placed on a lower‑cost tier and cannot be blocked by prior authorization or step therapy, unless a clinical committee decides they are not appropriate. The change applies to policies issued after the law takes effect.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Ask about A 11256

3 free questions a day, no account

History

  1. REFERRED TO INSURANCE

Sponsors

  • Josh Jensen · sponsor

Bill text

Read the official text ↗

Opens the legislature’s own copy.

Similar bills in other states

Loading the map of where bills like this one were filed.

Share

Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.

Track this bill

Get an email when A 11256 moves: committee action, floor votes, amendments and hearings. Free, no card.

Track A 11256 free

Or ask your AI assistant about A 11256 directly:

Add to Claude, ChatGPT or Cursor
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice